Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study on Intralesional Cyclosporine for Alopecia Areata
NCT07029204Phase 1Active, not recruiting
- Sponsor
- University of California, Davis
- Start
- Aug 2025
- Primary completion
- Oct 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alopecia areata comparing Blinded Cyclosporine Injection with Blinded Placebo Injection (2 arms). Primary endpoints: Severity of Alopecia Tool, Patient Reported Outcome for scalp hair assessment at Week 12 and 1 more. Started Aug 2025; status: active, not recruiting.
02
Drugs
cyclosporine
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07029204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07029204.